CDC42 and breast cancer: This selective inhibition of MBQ-167 may result from the different Cdc42-related GEF expression profiles in different types of breast cancer; MBQ-167 may only affect a subset of Cdc42-related GEFs that are activated in mesenchymal-like breast cancer cells [155].